Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 522

Results For "ABLE"

5843 News Found

Zydus Cadila receives U.S.FDA approval for leukaemia injection
Drug Approval | November 18, 2021

Zydus Cadila receives U.S.FDA approval for leukaemia injection

Nelarabine is in a class of medications called antimetabolites


Roche launches cobas 5800, a new molecular diagnostics system
Digitisation | November 18, 2021

Roche launches cobas 5800, a new molecular diagnostics system

The system is a compact new addition to the Roche Molecular portfolio, providing efficiency, simplicity and timely results to laboratories of all sizes.


US govt signs deal with GSK and Vir Biotechnology to buy sotrovimab, a Covid-19 treatment
Biotech | November 18, 2021

US govt signs deal with GSK and Vir Biotechnology to buy sotrovimab, a Covid-19 treatment

The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease


Biocon Biologics and Viatris announce US launch of Semglee
News | November 17, 2021

Biocon Biologics and Viatris announce US launch of Semglee

Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes


Cipla launches Spirofy for early diagnosis of COPD
Medical Device | November 17, 2021

Cipla launches Spirofy for early diagnosis of COPD

It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)


Sluggish exports to cap pharma revenue growth at 9% this fiscal
News | November 17, 2021

Sluggish exports to cap pharma revenue growth at 9% this fiscal

A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.


Private equity firm Carlyle partners with Viyash Life Sciences for pharma platform
News | November 17, 2021

Private equity firm Carlyle partners with Viyash Life Sciences for pharma platform

Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players


Pfizer seeks EUA from U.S. FDA for Covid-19 drug
Biotech | November 17, 2021

Pfizer seeks EUA from U.S. FDA for Covid-19 drug

If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2


Indian Pharmacopoeia Commission revises and adds new impurities and IP reference standards
Policy | November 16, 2021

Indian Pharmacopoeia Commission revises and adds new impurities and IP reference standards

The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards


Pre-diabetes is a much more serious issue in India: Fitterfly
News | November 16, 2021

Pre-diabetes is a much more serious issue in India: Fitterfly

Two out of three people under the age of 40 are at risk of prediabetes